Active
    Mainboard

    Anthem Biosciences Ltd

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Anthem Biosciences Ltd IPO opened on 14 Jul 2025 and closed on 16 Jul 2025, with a price band of ₹540–₹570 per share. The IPO had a lot size of 26 shares, requiring a minimum investment of ₹14,820 per lot at the upper price band. The issue size was ₹3395 crore, and the shares get listed on 21 Jul 2025.

    Anthem Biosciences Ltd IPO Details

    Listing Date

    21 Jul 2025

    Bid Price

    ₹540 - ₹570

    Lot Size

    26 Shares

    Minimum Investment

    ₹14,820 / Lot

    Issue Size

    ₹3395 Cr

    Employee Discount

    ₹50 per share

    Key Dates to Track

        Here are the important dates you need to know in order to participate in this IPO

    tick

    Offer Start Date

    14th Jul

    tick

    Offer End Date

    16th Jul

    tick

    Allotment Date

    17th Jul

    tick

    Refund Initiation

    18th Jul

    tick

    Demat Transfer

    18th Jul

    tick

    Listing Date

    21st Jul

    About Anthem Biosciences Ltd IPO

    Incorporated in 2006, Anthem Biosciences Limited operates as a Contract Research, Development, and Manufacturing Organization (CRDMO) with end-to-end capabilities spanning drug discovery, development, and manufacturing. The company caters to a global customer base, including emerging biotech firms and large pharmaceutical companies. Its product portfolio includes fermentation-based active pharmaceutical ingredients (APIs) such as enzymes, probiotics, peptides, biosimilars, and vitamin analogues. As of September 30, 2024, Anthem was involved in 196 projects, including discovery, early and late-phase, and commercial manufacturing projects. The company supported ten commercial molecules from discovery through production.
     

    Anthem Biosciences’ CRDMO platform comprises five primary modalities—RNAi, ADC, peptides, lipids, and oligonucleotides—along with four manufacturing capabilities: custom synthesis, flow chemistry, fermentation, and biotransformation. As of March and September 2024, the company served over 550 and 425 customers respectively, across more than 44 countries, including the U.S., Japan, and Europe. The company’s workforce includes 600 professionals from diverse scientific disciplines, and it holds one patent in India, seven internationally, with 24 global patent applications pending.

    Anthem Biosciences Ltd Shareholding Pattern

      Pre-Issue Post-Issue
    Promoter Group 76.87% 74.69%
    Public Group 23.13% 25.31%

    Anthem Biosciences Ltd IPO Reservation

    QIB Shares Offered 1,18,83,334 (19.95%)
    NII (HNI) Shares Offered 89,12,500 (14.96%)
    Retail Shares Offered 2,07,95,832 (34.91%)
    Anchor Investor Shares Offered 1,78,25,000 (29.93%)
    Total Shares Offered 5,95,61,404
    Total Shares With Anchor Investor 5,95,61,404

    Anthem Biosciences Ltd IPO Lot Size

    Application Lots Shares Amount
    Retail (Min) 1 26 ₹14,820
    Retail (Max) 13 338 ₹1,92,660
    S HNI (Min) 14 364 ₹2,07,480
    S HNI (Max) 67 1,742 ₹9,92,940
    B HNI (MIN) 68 1,768 ₹10,07,760

    Anthem Biosciences Ltd IPO Anchor Portion Size

    Bid Date July 11, 2025
    Shares Offered 1,78,24,999
    Anchor Investment Details 1,016.024943

    Anthem Biosciences Ltd IPO registrar

    KFin Techologies Ltd
    Phone Number +91 40 6716 2222
    Email Id einward.ris@kfintech.com
    Website www.kfintech.com

    Anthem Biosciences Ltd IPO Lead Manager

    1. JM Financial Ltd

    2. Citigroup Global Markets India Pvt Ltd

    3. J.P.Mprgan India Pvt Ltd

    4. Nomura Financial Advisors & Securities (India) P

    Anthem Biosciences Ltd Financial Information

    March 31, 2026 March 31, 2025 March 31, 2024
    Net Worth ₹3,042.52 Cr ₹2,409.86 Cr ₹1,924.65 Cr
    Reserves and Surplus ₹2,930.17 Cr ₹2,298.05 Cr ₹1,812.84 Cr
    Total Borrowing ₹51.07 Cr ₹108.95 Cr ₹232.52 Cr

    Anthem Biosciences Ltd IPO Subscription LIVE Status

    Category No. of shares offered No. of shares bid Subscription (Times)
    Qualified Institutional Buyers (QIBs) 1,25,43,518 2,29,10,95,976 182.6518
    Non Institutional Investors (NIIs) 94,07,639 39,84,69,578 42.356
    Retail Individual Investors (RIIs) 2,19,51,158 12,38,47,828 5.642
    Total 4,40,70,682 2,81,45,24,128 63.8639

    Strength of Anthem Biosciences Ltd

    • The Company offers comprehensive one-stop service capabilities across the drug life cycle (drug discovery, development and manufacturing) for both small molecules and biologics and it is the fastest growing Indian CRDMO.
    • Its innovation-focused approach has enabled it to offer a spectrum of technologically advanced solutions across modalities and manufacturing practices.
    • Wide specialty ingredients portfolio, well positioned to capitalize on the large market opportunity for niche specialty ingredients such as GLP-1, fermentation-based products,
    • Fully built-out automated manufacturing infrastructure with a consistent regulatory compliance track record.

    Risks Involved

    • Its business depends on the demand for the company CRDMO services, which contributed to 81.65% of its revenue from operations in Fiscal 2025. Any adverse impact on its CRDMO customers' business or the industries in which they operate may have a material adverse effect on the company business.
    • Developmental and commercial manufacturing contributed to 70.78% of its revenue from operations and 71.90% of the company total number of Projects in Fiscal 2025. Its business may be adversely affected by a failures in early phase developmental Projects or a failures to develop or manufacture commercially viable drugs, including for reasons that are not within its control.
    • Its financial performance is dependent on the success of the molecules the company manufacture, and its revenue from operations decreased in Fiscal 2023 compared to Fiscal 2022, partly attributable to the failures of a phase III molecule and withdrawal of a commercialized molecule. Accordingly, any unfavorable developments affecting these molecules' success rates, including failures to obtain the required regulatory approvals or withdrawal of commercialized molecules, may have an adverse impact on its business, financial condition, results of operations and prospects.
    • The company is subject to rapid advancements in technology which requires continuous investments. Its may not be successful in developing new technologies and improving its existing technologies to maintain the company competitive position. Any such failures to develop technologies may have a material and adverse impact on its business, financial condition and results of operations.
    • The company is subject to extensive government regulations, and if its fail to obtain, maintain or renew our statutory and regulatory licenses, permits and approvals required to operate the company business, results of operations and cash flows may be adversely affected.
    • The company depends on certain key customers for a significant portion of its revenues (its top 5 and top 10 customers contributed to 70.92% and 77.33%, respectively, of its revenue from operations in Fiscal 2025). Any inability to retain the company key customers or decrease in revenues from any of its key customers could negatively affect the company business and results of operations.
    • The company is dependent on its arrangements with DavosPharma, the affiliate of one of its Shareholders and also a Selling Shareholder, for the company business and marketing activities in the United States.
    • The company faces the risk of losing manufacturing revenue from services supplied to innovator pharmaceutical companies after the expiry of their patent protection period, which may lead to the availability of alternative formulations at a lower cost.
    • The company is highly dependent on its skilled workforce, in particular its R&D team, for the company day-to-day operations. The loss of, or its inability to attract or retain such persons may lead to knowledge loss and have a material adverse effect on the company business performance.
    • The Offer Price of its Equity Shares, the company price-to-earnings ratio, its enterprise value to EBITDA ratio and the company market capitalisation to total revenue from operations ratio may not be indicative of the trading price of its Equity Shares upon listing on the Stock Exchanges subsequent to the Offer and, as a result, you may lose a significant part or all of your investment.
    stock
    Invest in IPOs with ease

    Sign-in to invest with your demat account, or set up a new demat account for free

    Industry Outlook of Anthem Biosciences IPO

    • The global pharmaceutical industry is anticipated to reach a value of USD 2,076.0 billion by 2029, as per the F&S Report.

    • Contract Research Organizations (CROs) and Contract Development and Manufacturing Organizations (CDMOs) are increasingly combining their offerings.

    • This shift is leading to the development of integrated Contract Research, Development and Manufacturing Organization (CRDMO) business models.

    • The Indian CRDMO industry is expected to expand at a compound annual growth rate (CAGR) of 13.4% between 2024 and 2029.

    • By 2029, the Indian CRDMO market is estimated to reach a value of USD 15.4 billion.

    • The projected growth rate for India exceeds the global industry CAGR of 9.1% and several other regions.

    • Despite this trend, pharmaceutical companies continue to face challenges.

    • Key concerns include pricing pressures, a limited success rate of experimental compounds reaching commercialisation, and rising regulatory requirements.


    Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Anthem Biosciences IPO.

    Explore Other IPOs

    • Current IPOs
    • Upcoming IPOs
    • Closed IPOs
    • IPO Performance
    • All
    • MainBoard
    • SME
    INDOMIM LIMITED IPO
    icon
    Closing Tomorrow
    SME IPO
    Early Access
    Bidding Period
    23rd Jul 2026 - 7th Jul 2026
    Price Range
    ₹461.0 - 485.0
    IPO Size
    ₹38,12,10,99,264
    LOHIA CORP LIMITED IPO
    icon
    Closing Tomorrow
    SME IPO
    Early Access
    Bidding Period
    23rd Jul 2026 - 7th Jul 2026
    Price Range
    ₹404.0 - 425.0
    IPO Size
    ₹11,02,08,00,000
    XTRANET TECHNOLOGIES LIMITED IPO
    icon
    Closing Tomorrow
    SME IPO
    Early Access
    Bidding Period
    23rd Jul 2026 - 7th Jul 2026
    Price Range
    ₹120.0 - 127.0
    IPO Size
    ₹1,66,80,00,000
    Bidding Period
    24th Jul 2026 - 7th Jul 2026
    Price Range
    ₹123.0 - 133.0
    IPO Size
    ₹82,43,00,032
    ADVANCE TECHNOFORGE LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    27th Jul 2026 - 7th Jul 2026
    Price Range
    ₹95.0 - 95.0
    IPO Size
    ₹24,03,00,000
    Bidding Period
    27th Jul 2026 - 7th Jul 2026
    Price Range
    ₹65.0 - 69.0
    IPO Size
    ₹28,57,00,000
    Bidding Period
    28th Jul 2026 - 7th Jul 2026
    Price Range
    ₹285.0 - 301.0
    IPO Size
    ₹1,59,83,00,032
    • All
    • MainBoard
    • SME
    H R Hygiene Products Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    29th Jul 2026 - 7th Jul 2026
    Price Range
    ₹83.0 - 88.0
    IPO Size
    ₹53,95,00,032
    Bidding Period
    29th Jul 2026 - 7th Jul 2026
    Price Range
    ₹560.0 - 590.0
    IPO Size
    ₹92,75,21,99,680
    Dhaval Packaging Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Jul 2026 - 8th Aug 2026
    Price Range
    ₹92.0 - 97.0
    IPO Size
    ₹36,36,00,000
    Bidding Period
    31st Jul 2026 - 8th Aug 2026
    Price Range
    ₹151.0 - 159.0
    IPO Size
    ₹39,04,00,000
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    AceVector Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Advanced SysTek Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Advanta Enterprises Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Agilus Diagnostics Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Airox Technologies Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Ajay Poly Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Allchem Lifescience Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Annu Projects Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    AOne Steels India Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    APPL Containers Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    NO ACTIVE IPO HERE
    • All
    • MainBoard
    • SME
    CUBE HIGHWAYS TRUST IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    22nd Jul 2026 - 7th Jul 2026
    Price Range
    ₹151.0 - 152.0
    IPO Size
    ₹49,99,99,98,976
    Bidding Period
    22nd Jul 2026 - 7th Jul 2026
    Price Range
    ₹66.0 - 70.0
    IPO Size
    ₹18,90,00,000
    METALIC TECHNOFORGE LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    21st Jul 2026 - 7th Jul 2026
    Price Range
    ₹72.0 - 77.0
    IPO Size
    ₹49,96,00,000
    GULF LLOYDS INDIA LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    20th Jul 2026 - 7th Jul 2026
    Price Range
    ₹100.0 - 100.0
    IPO Size
    ₹18,19,00,000
    Bidding Period
    17th Jul 2026 - 7th Jul 2026
    Price Range
    ₹402.0 - 424.0
    IPO Size
    ₹4,49,99,99,744
    SOTEFIN BHARAT LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    16th Jul 2026 - 7th Jul 2026
    Price Range
    ₹178.0 - 187.0
    IPO Size
    ₹89,76,00,000
    ALPINE TEXWORLD LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    14th Jul 2026 - 7th Jul 2026
    Price Range
    ₹100.0 - 105.0
    IPO Size
    ₹1,26,24,99,968
    Bidding Period
    14th Jul 2026 - 7th Jul 2026
    Price Range
    ₹315.0 - 331.0
    IPO Size
    ₹1,60,33,99,936
    SBI FUNDS MANAGEMENT LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    14th Jul 2026 - 7th Jul 2026
    Price Range
    ₹545.0 - 574.0
    IPO Size
    ₹97,95,32,02,176
    Bidding Period
    9th Jul 2026 - 7th Jul 2026
    Price Range
    ₹203.0 - 214.0
    IPO Size
    ₹7,42,00,00,256
    HAPPY STEELS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    9th Jul 2026 - 7th Jul 2026
    Price Range
    ₹62.0 - 66.0
    IPO Size
    ₹25,08,00,000
    DEVSON CATALYST LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    9th Jul 2026 - 7th Jul 2026
    Price Range
    ₹112.0 - 118.0
    IPO Size
    ₹42,34,00,000
    KUSUMGAR LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    8th Jul 2026 - 7th Jul 2026
    Price Range
    ₹398.0 - 419.0
    IPO Size
    ₹6,49,99,99,744
    Bidding Period
    3rd Jul 2026 - 7th Jul 2026
    Price Range
    ₹94.0 - 99.0
    IPO Size
    ₹47,91,00,000
    KNACK PACKAGING LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    1st Jul 2026 - 7th Jul 2026
    Price Range
    ₹161.0 - 170.0
    IPO Size
    ₹4,39,49,99,808
    KRATIKAL TECH LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Jun 2026 - 7th Jul 2026
    Price Range
    ₹128.0 - 135.0
    IPO Size
    ₹39,69,00,000
    SEEMAX RESOURCES LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Jun 2026 - 7th Jul 2026
    Price Range
    ₹134.0 - 141.0
    IPO Size
    ₹19,74,00,000
    Bidding Period
    30th Jun 2026 - 7th Jul 2026
    Price Range
    ₹80.0 - 84.0
    IPO Size
    ₹27,22,00,000
    ATHARVA POLYPLAST LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Jun 2026 - 7th Jul 2026
    Price Range
    ₹55.0 - 60.0
    IPO Size
    ₹27,00,00,000
    Bidding Period
    30th Jun 2026 - 7th Jul 2026
    Price Range
    ₹220.0 - 220.0
    IPO Size
    ₹37,36,00,000
    • All
    • MainBoard
    • SME
    Issue Prize
    424.00
    Listing Day Close
    528.50(24.76%)
    SOTEFIN BHARAT LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    187.00
    Listing Day Close
    215.25(14.97%)
    ALPINE TEXWORLD LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    105.00
    Listing Day Close
    99.75(-4.76%)
    Issue Prize
    331.00
    Listing Day Close
    660.30(99.40%)
    SBI FUNDS MANAGEMENT LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    574.00
    Listing Day Close
    609.90(6.27%)
    Issue Prize
    214.00
    Listing Day Close
    262.85(22.90%)
    HAPPY STEELS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    66.00
    Listing Day Close
    68.50(4.55%)
    DEVSON CATALYST LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    118.00
    Listing Day Close
    205.95(74.58%)
    KUSUMGAR LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    419.00
    Listing Day Close
    604.45(44.15%)
    Issue Prize
    99.00
    Listing Day Close
    174.30(75.76%)
    KNACK PACKAGING LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    170.00
    Listing Day Close
    182.70(7.65%)
    KRATIKAL TECH LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    135.00
    Listing Day Close
    182.40(34.81%)
    SEEMAX RESOURCES LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    141.00
    Listing Day Close
    107.20(-24.11%)
    Issue Prize
    84.00
    Listing Day Close
    93.45(10.71%)
    ATHARVA POLYPLAST LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    60.00
    Listing Day Close
    72.45(20.00%)
    Issue Prize
    220.00
    Listing Day Close
    438.90(99.55%)
    VINIT MOBILE LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    158.00
    Listing Day Close
    147.25(-6.96%)
    Issue Prize
    70.00
    Listing Day Close
    82.16(17.14%)
    AASTHA SPINTEX LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    136.00
    Listing Day Close
    136.45(0.00%)
    Issue Prize
    99.00
    Listing Day Close
    174.30(75.76%)

    Frequently Asked Questions

    What is Anthem Biosciences Ltd IPO?

    Answer Field

    Anthem Biosciences Ltd IPO is a Mainboard IPO of 5,95,61,404 equity shares of a face value of ₹2 aggregating up to ₹3395 Crores. The issue is priced at ₹540 to ₹570 per share. The minimum order quantity is 26 Shares. The IPO opens on July 14, 2025, and closes on July 16, 2025. KFin Techologies Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE,NSE.

    When Anthem Biosciences Ltd IPO will open?

    Answer Field

    The Anthem Biosciences Ltd IPO opens on July 14, 2025 and closes on July 16, 2025.

    What is the lot size of Anthem Biosciences Ltd?

    Answer Field

    Anthem Biosciences Ltd lot size is 26 shares, and the minimum amount required is ₹14,820.

    How to apply for Anthem Biosciences Ltd IPO?

    Answer Field

    You can apply in Anthem Biosciences Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

    • Login to Bajaj Broking account App/Website & click on IPO
    • Enter the number of lots and price at which you wish to apply.
    • Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
    • You will receive a mandate notification to block funds in your UPI app.
    • Approve the mandate request on your UPI and funds will be blocked.

    When is Anthem Biosciences Ltd IPO allotment?

    Answer Field

    The finalization of Basis of Allotment for Anthem Biosciences Ltd IPO will be done on July 17, 2025, and the allotted shares will be credited to your demat account by July 18, 2025.

    When is Anthem Biosciences Ltd IPO listing date?

    Answer Field

    The Anthem Biosciences Ltd listing date is July 21, 2025.

    Who is the registrar of Anthem Biosciences Ltd IPO?

    Answer Field

    The registrar of Anthem Biosciences Ltd IPO is KFin Techologies Ltd

    Which company is the book-running lead manager of the IPO?

    Answer Field

    JM Financial Ltd,Citigroup Global Markets India Pvt Ltd,J.P.Mprgan India Pvt Ltd,Nomura Financial Advisors & Securities (India) P will be the book-running lead manager of this IPO.

    What is the fresh issue of Anthem Biosciences Ltd IPO?

    Answer Field

    The fresh issue size is ₹[-] Crores equity shares.

    What minimum lot size can retail subscribers subscribe to Anthem Biosciences Ltd?

    Answer Field

    Retail investors can subscribe to a minimum of one lot, 26 shares and ₹14,820 amount.

    How can I approve the UPI mandate request for Anthem Biosciences Ltd IPO?

    Answer Field

    To apply for Anthem Biosciences Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

    What is the price range of Anthem Biosciences Ltd?

    Answer Field

    The price of each Anthem Biosciences Ltd share will be ranging in between ₹540 to ₹570 per share.

    What is the cut-off time for the UPI mandate for Anthem Biosciences Ltd IPO?

    Answer Field

    The cut-off time for the UPI mandate confirmation is 5:00 PM, July 16, 2025.

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |